Suppr超能文献

抗Sm抗体和抗RNP抗体。

Anti-Sm and anti-RNP antibodies.

作者信息

Migliorini P, Baldini C, Rocchi V, Bombardieri S

机构信息

Clinical Immunology Unit, Department of Internal Medicine, University of Pisa, Italy.

出版信息

Autoimmunity. 2005 Feb;38(1):47-54. doi: 10.1080/08916930400022715.

Abstract

Among anti-nuclear antibodies, anti-Sm and anti-RNP antibodies are of the utmost importance in clinical practice. Anti-Sm antibodies are directed against 7 proteins (B/B', D1, D2, D3, E, F, G) that constitute the common core of U1, U2, U4 and U5 small nuclear ribonucleoprotein (snRNP) particles; B/B', D1 and D3 are more frequently targeted. Anti-RNP antibodies react with proteins (70 Kd, A, C) that are associated with U1 RNA and form U1snRNP. Anti-Sm and anti-RNP antibodies are directed towards both discontinuous and linear epitopes which are either contained in the protein sequence or are post-translationally modified. The assays to detect anti-Sm and anti-RNP antibodies are counterimmunoelectrophoresis (CIE), immunoblot, and ELISA, based on purified or recombinant proteins or synthetic peptides. Anti-Sm antibodies are detectable in a percentage of SLE patients comprised between 5 and 30%; they are more prevalent in blacks and because of their high specificity for SLE have been included in the serological criteria for diagnosing the disease.Anti-RNP are detectable in 25-47% of SLE patients; high titers of anti-RNP antibodies are diagnostic of mixed connective tissue disorder (MCTD). The measurement of anti-Sm and anti-RNP antibodies is more important in the diagnosis of SLE than in the follow-up of patients. However, anti-RNP antibodies are more prevalent in patients with Raynaud's phenomenon and are associated with milder renal involvement. On the contrary, anti-Sm antibodies are associated with the severity and the activity of renal involvement. The specificity of anti-Sm antibodies, together with epidemiological data, suggest that Epstein-Barr virus infection has the potential to induce anti-Sm antibodies by molecular mimicry.Anti-nuclear antibodies, a hallmark of the systemic autoimmune diseases, include several populations of antibodies with different specificities. Among them, anti-Sm and anti-RNP antibodies are of the utmost importance in clinical practice; in research, the study of the mechanisms inducing their production has opened up new perspectives and helped to elucidate the pathogenesis of autoimmune disorders.

摘要

在抗核抗体中,抗Sm和抗RNP抗体在临床实践中极为重要。抗Sm抗体针对构成U1、U2、U4和U5小核核糖核蛋白(snRNP)颗粒共同核心的7种蛋白质(B/B'、D1、D2、D3、E、F、G);B/B'、D1和D3是更常被靶向的。抗RNP抗体与与U1 RNA相关并形成U1snRNP的蛋白质(70 Kd、A、C)发生反应。抗Sm和抗RNP抗体针对的是不连续和线性表位,这些表位要么包含在蛋白质序列中,要么经过翻译后修饰。检测抗Sm和抗RNP抗体的检测方法有对流免疫电泳(CIE)、免疫印迹和ELISA,基于纯化或重组蛋白或合成肽。在5%至30%的系统性红斑狼疮(SLE)患者中可检测到抗Sm抗体;它们在黑人中更为普遍,并且由于其对SLE的高特异性已被纳入该疾病的血清学诊断标准。在25%至47%的SLE患者中可检测到抗RNP抗体;高滴度的抗RNP抗体可诊断混合性结缔组织病(MCTD)。抗Sm和抗RNP抗体的检测在SLE诊断中比在患者随访中更重要。然而,抗RNP抗体在雷诺现象患者中更为普遍,且与较轻的肾脏受累相关。相反,抗Sm抗体与肾脏受累的严重程度和活动度相关。抗Sm抗体的特异性以及流行病学数据表明,爱泼斯坦-巴尔病毒感染有可能通过分子模拟诱导抗Sm抗体。抗核抗体是系统性自身免疫性疾病的一个标志,包括几种具有不同特异性的抗体群体。其中,抗Sm和抗RNP抗体在临床实践中极为重要;在研究中,对诱导其产生机制的研究开辟了新的视角,并有助于阐明自身免疫性疾病的发病机制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验